A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma

Published:2020-02-26 Issue:7 Volume:61 Page:1555-1564
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Allen Pamela B.¹,Ayers Amy¹,Behera Madhusmita²,Evens Andrew M.³,Flowers Christopher⁴

Affiliation:

1. Department of Hematology and Oncology, Winship Cancer Institution of Emory University, Atlanta, GA, USA;

2. Department of Research Informatics, Winship Cancer Institution of Emory University, Atlanta, GA, USA;

3. Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA;

4. Myeloma and Lymphoma Division, MD Anderson Cancer Center, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1731497

Reference39 articles.

1. Disparities in survival by insurance status in patients with Hodgkin lymphoma

2. Improved survival time trends in Hodgkin's lymphoma

3. Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis

4. A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era

5. Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia;Leukemia & Lymphoma;2022-06-07

2. The effect of decision support systems on pain in patients with cancer: A systematic review and meta‐analysis of randomized controlled trials;Journal of Nursing Scholarship;2022-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3